nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ovarian cancer—cervical cancer	0.678	1	CtDrD
Paclitaxel—ABCG2—Topotecan—cervical cancer	0.103	0.634	CbGbCtD
Paclitaxel—ABCB1—Topotecan—cervical cancer	0.0371	0.229	CbGbCtD
Paclitaxel—CYP3A4—Topotecan—cervical cancer	0.0222	0.137	CbGbCtD
Paclitaxel—Neutropenic colitis—Topotecan—cervical cancer	0.00738	0.131	CcSEcCtD
Paclitaxel—BCL2—Irinotecan—Topotecan—cervical cancer	0.00319	1	CbGdCrCtD
Paclitaxel—Acute leukaemia—Topotecan—cervical cancer	0.00298	0.053	CcSEcCtD
Paclitaxel—CYP19A1—semen—cervical cancer	0.00255	0.0376	CbGeAlD
Paclitaxel—Docetaxel—EGFR—cervical cancer	0.00215	1	CrCbGaD
Paclitaxel—Myelosuppression—Topotecan—cervical cancer	0.00181	0.0323	CcSEcCtD
Paclitaxel—Mucosal inflammation—Topotecan—cervical cancer	0.00154	0.0274	CcSEcCtD
Paclitaxel—Febrile neutropenia—Topotecan—cervical cancer	0.00141	0.0252	CcSEcCtD
Paclitaxel—Intestinal obstruction—Topotecan—cervical cancer	0.00125	0.0222	CcSEcCtD
Paclitaxel—Neuralgia—Topotecan—cervical cancer	0.00122	0.0218	CcSEcCtD
Paclitaxel—Interstitial lung disease—Topotecan—cervical cancer	0.0012	0.0214	CcSEcCtD
Paclitaxel—MAP4—uterine cervix—cervical cancer	0.00116	0.0171	CbGeAlD
Paclitaxel—Pleural effusion—Topotecan—cervical cancer	0.00111	0.0198	CcSEcCtD
Paclitaxel—Rash erythematous—Topotecan—cervical cancer	0.00111	0.0198	CcSEcCtD
Paclitaxel—MAP4—decidua—cervical cancer	0.0011	0.0162	CbGeAlD
Paclitaxel—MAP4—renal system—cervical cancer	0.00108	0.016	CbGeAlD
Paclitaxel—TUBB1—decidua—cervical cancer	0.00108	0.0159	CbGeAlD
Paclitaxel—BCL2—epithelium—cervical cancer	0.00106	0.0156	CbGeAlD
Paclitaxel—Rigors—Topotecan—cervical cancer	0.00104	0.0186	CcSEcCtD
Paclitaxel—BCL2—renal system—cervical cancer	0.000984	0.0145	CbGeAlD
Paclitaxel—Extravasation—Topotecan—cervical cancer	0.000975	0.0174	CcSEcCtD
Paclitaxel—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000974	0.032	CbGpPWpGaD
Paclitaxel—MAP4—uterus—cervical cancer	0.000964	0.0142	CbGeAlD
Paclitaxel—BCL2—endometrium—cervical cancer	0.000951	0.014	CbGeAlD
Paclitaxel—BCL2—Interleukin-11 Signaling Pathway—PIAS3—cervical cancer	0.000949	0.0311	CbGpPWpGaD
Paclitaxel—Hyperbilirubinaemia—Topotecan—cervical cancer	0.000936	0.0167	CcSEcCtD
Paclitaxel—MAP2—uterine cervix—cervical cancer	0.000911	0.0134	CbGeAlD
Paclitaxel—Blood bilirubin increased—Topotecan—cervical cancer	0.0009	0.016	CcSEcCtD
Paclitaxel—NR1I2—Nuclear Receptors—RARB—cervical cancer	0.000891	0.0292	CbGpPWpGaD
Paclitaxel—Bone pain—Topotecan—cervical cancer	0.000888	0.0158	CcSEcCtD
Paclitaxel—BCL2—uterus—cervical cancer	0.000877	0.0129	CbGeAlD
Paclitaxel—MAP2—decidua—cervical cancer	0.000868	0.0128	CbGeAlD
Paclitaxel—MAP4—female reproductive system—cervical cancer	0.000867	0.0128	CbGeAlD
Paclitaxel—Respiratory failure—Topotecan—cervical cancer	0.000867	0.0154	CcSEcCtD
Paclitaxel—MAPT—Caspase-mediated cleavage of cytoskeletal proteins—CASP8—cervical cancer	0.000856	0.0281	CbGpPWpGaD
Paclitaxel—Pulmonary embolism—Topotecan—cervical cancer	0.000851	0.0151	CcSEcCtD
Paclitaxel—MAP2—endometrium—cervical cancer	0.000824	0.0121	CbGeAlD
Paclitaxel—Colitis—Topotecan—cervical cancer	0.000817	0.0145	CcSEcCtD
Paclitaxel—Neuropathy—Topotecan—cervical cancer	0.000799	0.0142	CcSEcCtD
Paclitaxel—MAP2—mammalian vulva—cervical cancer	0.000797	0.0118	CbGeAlD
Paclitaxel—MAP4—female gonad—cervical cancer	0.000789	0.0116	CbGeAlD
Paclitaxel—BCL2—female reproductive system—cervical cancer	0.000788	0.0116	CbGeAlD
Paclitaxel—MAP4—vagina—cervical cancer	0.000784	0.0116	CbGeAlD
Paclitaxel—Rash maculo-papular—Topotecan—cervical cancer	0.000774	0.0138	CcSEcCtD
Paclitaxel—Neoplasm—Topotecan—cervical cancer	0.000769	0.0137	CcSEcCtD
Paclitaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.000759	0.0249	CbGpPWpGaD
Paclitaxel—Sepsis—Topotecan—cervical cancer	0.000739	0.0131	CcSEcCtD
Paclitaxel—Ear pain—Topotecan—cervical cancer	0.000724	0.0129	CcSEcCtD
Paclitaxel—BCL2—female gonad—cervical cancer	0.000717	0.0106	CbGeAlD
Paclitaxel—TUBB4A—uterine cervix—cervical cancer	0.000704	0.0104	CbGeAlD
Paclitaxel—NR1I2—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000704	0.0231	CbGpPWpGaD
Paclitaxel—SLCO1B3—vagina—cervical cancer	0.000686	0.0101	CbGeAlD
Paclitaxel—MAP2—female reproductive system—cervical cancer	0.000683	0.0101	CbGeAlD
Paclitaxel—TUBB2B—uterine cervix—cervical cancer	0.000681	0.01	CbGeAlD
Paclitaxel—TUBB4A—renal system—cervical cancer	0.000659	0.00971	CbGeAlD
Paclitaxel—MAPT—Caspase-mediated cleavage of cytoskeletal proteins—CASP3—cervical cancer	0.000648	0.0213	CbGpPWpGaD
Paclitaxel—MAPT—lymph node—cervical cancer	0.000645	0.00951	CbGeAlD
Paclitaxel—TUBB—uterine cervix—cervical cancer	0.000644	0.00949	CbGeAlD
Paclitaxel—TUBB2A—uterine cervix—cervical cancer	0.000641	0.00944	CbGeAlD
Paclitaxel—TUBB6—epithelium—cervical cancer	0.000637	0.00939	CbGeAlD
Paclitaxel—TUBB2B—renal system—cervical cancer	0.000637	0.00938	CbGeAlD
Paclitaxel—TUBB6—uterine cervix—cervical cancer	0.000632	0.00931	CbGeAlD
Paclitaxel—Lethargy—Topotecan—cervical cancer	0.00063	0.0112	CcSEcCtD
Paclitaxel—MAP2—female gonad—cervical cancer	0.000621	0.00916	CbGeAlD
Paclitaxel—MAP2—vagina—cervical cancer	0.000617	0.0091	CbGeAlD
Paclitaxel—TUBB2B—endometrium—cervical cancer	0.000616	0.00907	CbGeAlD
Paclitaxel—TUBB—decidua—cervical cancer	0.000614	0.00904	CbGeAlD
Paclitaxel—TUBB2A—decidua—cervical cancer	0.00061	0.009	CbGeAlD
Paclitaxel—TUBB6—decidua—cervical cancer	0.000602	0.00887	CbGeAlD
Paclitaxel—TUBB2B—mammalian vulva—cervical cancer	0.000595	0.00878	CbGeAlD
Paclitaxel—TUBB6—renal system—cervical cancer	0.000591	0.00871	CbGeAlD
Paclitaxel—Cardiac arrest—Topotecan—cervical cancer	0.000587	0.0105	CcSEcCtD
Paclitaxel—TUBB4A—uterus—cervical cancer	0.000587	0.00865	CbGeAlD
Paclitaxel—TUBB—endometrium—cervical cancer	0.000582	0.00859	CbGeAlD
Paclitaxel—TUBB2A—endometrium—cervical cancer	0.000579	0.00854	CbGeAlD
Paclitaxel—TUBB6—endometrium—cervical cancer	0.000571	0.00842	CbGeAlD
Paclitaxel—BCL2—C-MYB transcription factor network—PIAS3—cervical cancer	0.000566	0.0186	CbGpPWpGaD
Paclitaxel—TUBB—mammalian vulva—cervical cancer	0.000563	0.00831	CbGeAlD
Paclitaxel—TUBB2A—mammalian vulva—cervical cancer	0.00056	0.00826	CbGeAlD
Paclitaxel—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.000556	0.0099	CcSEcCtD
Paclitaxel—Cramp muscle—Topotecan—cervical cancer	0.000556	0.0099	CcSEcCtD
Paclitaxel—ABCC10—uterine cervix—cervical cancer	0.000553	0.00815	CbGeAlD
Paclitaxel—TUBB6—mammalian vulva—cervical cancer	0.000553	0.00815	CbGeAlD
Paclitaxel—TUBB4B—uterine cervix—cervical cancer	0.000549	0.0081	CbGeAlD
Paclitaxel—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000545	0.0097	CcSEcCtD
Paclitaxel—TUBB—uterus—cervical cancer	0.000537	0.00791	CbGeAlD
Paclitaxel—TUBB2A—uterus—cervical cancer	0.000534	0.00787	CbGeAlD
Paclitaxel—TUBB4A—female reproductive system—cervical cancer	0.000528	0.00778	CbGeAlD
Paclitaxel—ABCC10—decidua—cervical cancer	0.000527	0.00777	CbGeAlD
Paclitaxel—TUBB6—uterus—cervical cancer	0.000527	0.00776	CbGeAlD
Paclitaxel—TUBB4B—decidua—cervical cancer	0.000523	0.00771	CbGeAlD
Paclitaxel—ABCC10—renal system—cervical cancer	0.000518	0.00763	CbGeAlD
Paclitaxel—TUBB4B—renal system—cervical cancer	0.000514	0.00757	CbGeAlD
Paclitaxel—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000511	0.0168	CbGpPWpGaD
Paclitaxel—TUBB2B—female reproductive system—cervical cancer	0.00051	0.00752	CbGeAlD
Paclitaxel—MAP4—lymph node—cervical cancer	0.000507	0.00748	CbGeAlD
Paclitaxel—Pancytopenia—Topotecan—cervical cancer	0.000507	0.00902	CcSEcCtD
Paclitaxel—ABCC10—endometrium—cervical cancer	0.0005	0.00738	CbGeAlD
Paclitaxel—Neutropenia—Topotecan—cervical cancer	0.000499	0.00889	CcSEcCtD
Paclitaxel—TUBB4B—endometrium—cervical cancer	0.000497	0.00732	CbGeAlD
Paclitaxel—Weight increased—Topotecan—cervical cancer	0.000486	0.00865	CcSEcCtD
Paclitaxel—ABCC10—mammalian vulva—cervical cancer	0.000484	0.00713	CbGeAlD
Paclitaxel—TUBB4B—mammalian vulva—cervical cancer	0.000481	0.00708	CbGeAlD
Paclitaxel—TUBB4A—female gonad—cervical cancer	0.00048	0.00708	CbGeAlD
Paclitaxel—TUBB2A—female reproductive system—cervical cancer	0.00048	0.00707	CbGeAlD
Paclitaxel—Pneumonia—Topotecan—cervical cancer	0.000479	0.00852	CcSEcCtD
Paclitaxel—Infestation—Topotecan—cervical cancer	0.000476	0.00847	CcSEcCtD
Paclitaxel—Infestation NOS—Topotecan—cervical cancer	0.000476	0.00847	CcSEcCtD
Paclitaxel—TUBB6—female reproductive system—cervical cancer	0.000473	0.00698	CbGeAlD
Paclitaxel—Neuropathy peripheral—Topotecan—cervical cancer	0.000467	0.00831	CcSEcCtD
Paclitaxel—Stomatitis—Topotecan—cervical cancer	0.000464	0.00826	CcSEcCtD
Paclitaxel—TUBB2B—female gonad—cervical cancer	0.000464	0.00684	CbGeAlD
Paclitaxel—TUBB2B—vagina—cervical cancer	0.000461	0.0068	CbGeAlD
Paclitaxel—ABCC10—uterus—cervical cancer	0.000461	0.0068	CbGeAlD
Paclitaxel—BCL2—lymph node—cervical cancer	0.000461	0.0068	CbGeAlD
Paclitaxel—TUBB4B—uterus—cervical cancer	0.000458	0.00675	CbGeAlD
Paclitaxel—MAP2—LKB1 signaling events—MTOR—cervical cancer	0.000452	0.0149	CbGpPWpGaD
Paclitaxel—Hepatobiliary disease—Topotecan—cervical cancer	0.00045	0.00801	CcSEcCtD
Paclitaxel—Epistaxis—Topotecan—cervical cancer	0.000449	0.00799	CcSEcCtD
Paclitaxel—TUBB—female gonad—cervical cancer	0.000439	0.00647	CbGeAlD
Paclitaxel—TUBB2A—female gonad—cervical cancer	0.000437	0.00644	CbGeAlD
Paclitaxel—TUBB—vagina—cervical cancer	0.000436	0.00643	CbGeAlD
Paclitaxel—TUBB2A—vagina—cervical cancer	0.000434	0.0064	CbGeAlD
Paclitaxel—TUBB6—female gonad—cervical cancer	0.000431	0.00635	CbGeAlD
Paclitaxel—Haemoglobin—Topotecan—cervical cancer	0.00043	0.00764	CcSEcCtD
Paclitaxel—Rhinitis—Topotecan—cervical cancer	0.000428	0.00763	CcSEcCtD
Paclitaxel—TUBB6—vagina—cervical cancer	0.000428	0.00631	CbGeAlD
Paclitaxel—Haemorrhage—Topotecan—cervical cancer	0.000427	0.00761	CcSEcCtD
Paclitaxel—Hypoaesthesia—Topotecan—cervical cancer	0.000425	0.00757	CcSEcCtD
Paclitaxel—Pharyngitis—Topotecan—cervical cancer	0.000424	0.00755	CcSEcCtD
Paclitaxel—CYP19A1—endometrium—cervical cancer	0.000421	0.0062	CbGeAlD
Paclitaxel—ABCC2—renal system—cervical cancer	0.000416	0.00613	CbGeAlD
Paclitaxel—ABCC10—female reproductive system—cervical cancer	0.000414	0.00611	CbGeAlD
Paclitaxel—CYP1B1—decidua—cervical cancer	0.000414	0.00611	CbGeAlD
Paclitaxel—MAPT—Notch Signaling Pathway—NOTCH2—cervical cancer	0.000413	0.0136	CbGpPWpGaD
Paclitaxel—TUBB4B—female reproductive system—cervical cancer	0.000411	0.00607	CbGeAlD
Paclitaxel—CYP1B1—renal system—cervical cancer	0.000407	0.006	CbGeAlD
Paclitaxel—MAP2—lymph node—cervical cancer	0.000399	0.00589	CbGeAlD
Paclitaxel—ABCC1—uterine cervix—cervical cancer	0.000391	0.00577	CbGeAlD
Paclitaxel—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000389	0.0128	CbGpPWpGaD
Paclitaxel—CYP19A1—uterus—cervical cancer	0.000388	0.00572	CbGeAlD
Paclitaxel—Angiopathy—Topotecan—cervical cancer	0.000388	0.0069	CcSEcCtD
Paclitaxel—Immune system disorder—Topotecan—cervical cancer	0.000386	0.00687	CcSEcCtD
Paclitaxel—Mediastinal disorder—Topotecan—cervical cancer	0.000385	0.00685	CcSEcCtD
Paclitaxel—Chills—Topotecan—cervical cancer	0.000383	0.00682	CcSEcCtD
Paclitaxel—Alopecia—Topotecan—cervical cancer	0.000378	0.00672	CcSEcCtD
Paclitaxel—ABCC10—female gonad—cervical cancer	0.000377	0.00556	CbGeAlD
Paclitaxel—BCL2—Direct p53 effectors—POU4F1—cervical cancer	0.000376	0.0123	CbGpPWpGaD
Paclitaxel—ABCC10—vagina—cervical cancer	0.000375	0.00553	CbGeAlD
Paclitaxel—TUBB4B—female gonad—cervical cancer	0.000374	0.00552	CbGeAlD
Paclitaxel—ABCC1—decidua—cervical cancer	0.000373	0.0055	CbGeAlD
Paclitaxel—TUBB4B—vagina—cervical cancer	0.000372	0.00549	CbGeAlD
Paclitaxel—Malnutrition—Topotecan—cervical cancer	0.000372	0.00662	CcSEcCtD
Paclitaxel—CYP19A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000372	0.0122	CbGpPWpGaD
Paclitaxel—CYP1B1—uterus—cervical cancer	0.000363	0.00534	CbGeAlD
Paclitaxel—Back pain—Topotecan—cervical cancer	0.00036	0.0064	CcSEcCtD
Paclitaxel—CYP1B1—Tryptophan metabolism—UBE3A—cervical cancer	0.000358	0.0117	CbGpPWpGaD
Paclitaxel—Muscle spasms—Topotecan—cervical cancer	0.000358	0.00637	CcSEcCtD
Paclitaxel—ABCC1—endometrium—cervical cancer	0.000354	0.00522	CbGeAlD
Paclitaxel—BCL2—Validated targets of C-MYC transcriptional repression—WNT5A—cervical cancer	0.000353	0.0116	CbGpPWpGaD
Paclitaxel—CYP19A1—female reproductive system—cervical cancer	0.000349	0.00514	CbGeAlD
Paclitaxel—Ill-defined disorder—Topotecan—cervical cancer	0.000345	0.00614	CcSEcCtD
Paclitaxel—Anaemia—Topotecan—cervical cancer	0.000344	0.00612	CcSEcCtD
Paclitaxel—ABCC1—mammalian vulva—cervical cancer	0.000342	0.00505	CbGeAlD
Paclitaxel—MAPT—Apoptotic cleavage of cellular proteins—CASP8—cervical cancer	0.00034	0.0112	CbGpPWpGaD
Paclitaxel—Angioedema—Topotecan—cervical cancer	0.00034	0.00605	CcSEcCtD
Paclitaxel—MAPT—Notch Signaling Pathway—HES1—cervical cancer	0.000339	0.0111	CbGpPWpGaD
Paclitaxel—Malaise—Topotecan—cervical cancer	0.000336	0.00597	CcSEcCtD
Paclitaxel—Leukopenia—Topotecan—cervical cancer	0.000333	0.00593	CcSEcCtD
Paclitaxel—ABCC2—female reproductive system—cervical cancer	0.000333	0.00491	CbGeAlD
Paclitaxel—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000332	0.0109	CbGpPWpGaD
Paclitaxel—ABCC1—uterus—cervical cancer	0.000326	0.00481	CbGeAlD
Paclitaxel—CYP1B1—female reproductive system—cervical cancer	0.000326	0.0048	CbGeAlD
Paclitaxel—Cough—Topotecan—cervical cancer	0.000325	0.00578	CcSEcCtD
Paclitaxel—ABCG2—uterine cervix—cervical cancer	0.000324	0.00477	CbGeAlD
Paclitaxel—CYP19A1—female gonad—cervical cancer	0.000317	0.00468	CbGeAlD
Paclitaxel—Myalgia—Topotecan—cervical cancer	0.000317	0.00564	CcSEcCtD
Paclitaxel—Chest pain—Topotecan—cervical cancer	0.000317	0.00564	CcSEcCtD
Paclitaxel—Arthralgia—Topotecan—cervical cancer	0.000317	0.00564	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000315	0.0056	CcSEcCtD
Paclitaxel—Discomfort—Topotecan—cervical cancer	0.000313	0.00557	CcSEcCtD
Paclitaxel—CYP2C8—renal system—cervical cancer	0.000312	0.00459	CbGeAlD
Paclitaxel—ABCG2—decidua—cervical cancer	0.000309	0.00455	CbGeAlD
Paclitaxel—TUBB4A—lymph node—cervical cancer	0.000309	0.00455	CbGeAlD
Paclitaxel—Anaphylactic shock—Topotecan—cervical cancer	0.000304	0.0054	CcSEcCtD
Paclitaxel—Infection—Topotecan—cervical cancer	0.000302	0.00537	CcSEcCtD
Paclitaxel—CYP2C8—endometrium—cervical cancer	0.000301	0.00444	CbGeAlD
Paclitaxel—CYP3A5—uterine cervix—cervical cancer	0.000301	0.00443	CbGeAlD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—WNT2—cervical cancer	0.0003	0.00986	CbGpPWpGaD
Paclitaxel—TUBB2B—lymph node—cervical cancer	0.000298	0.0044	CbGeAlD
Paclitaxel—Nervous system disorder—Topotecan—cervical cancer	0.000298	0.0053	CcSEcCtD
Paclitaxel—Thrombocytopenia—Topotecan—cervical cancer	0.000297	0.00529	CcSEcCtD
Paclitaxel—CYP1B1—female gonad—cervical cancer	0.000297	0.00437	CbGeAlD
Paclitaxel—Skin disorder—Topotecan—cervical cancer	0.000295	0.00525	CcSEcCtD
Paclitaxel—TUBB8—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000294	0.00964	CbGpPWpGaD
Paclitaxel—Hyperhidrosis—Topotecan—cervical cancer	0.000294	0.00522	CcSEcCtD
Paclitaxel—ABCG2—endometrium—cervical cancer	0.000293	0.00432	CbGeAlD
Paclitaxel—Anorexia—Topotecan—cervical cancer	0.000289	0.00515	CcSEcCtD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000285	0.00936	CbGpPWpGaD
Paclitaxel—ABCG2—mammalian vulva—cervical cancer	0.000283	0.00418	CbGeAlD
Paclitaxel—TUBB—lymph node—cervical cancer	0.000282	0.00416	CbGeAlD
Paclitaxel—CYP3A5—renal system—cervical cancer	0.000281	0.00415	CbGeAlD
Paclitaxel—TUBB2A—lymph node—cervical cancer	0.000281	0.00414	CbGeAlD
Paclitaxel—TUBB6—lymph node—cervical cancer	0.000277	0.00408	CbGeAlD
Paclitaxel—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000277	0.00492	CcSEcCtD
Paclitaxel—Paraesthesia—Topotecan—cervical cancer	0.000273	0.00485	CcSEcCtD
Paclitaxel—BCL2—IL2 signaling events mediated by PI3K—TERT—cervical cancer	0.000272	0.00894	CbGpPWpGaD
Paclitaxel—Dyspnoea—Topotecan—cervical cancer	0.000271	0.00482	CcSEcCtD
Paclitaxel—ABCG2—uterus—cervical cancer	0.00027	0.00398	CbGeAlD
Paclitaxel—Dyspepsia—Topotecan—cervical cancer	0.000267	0.00476	CcSEcCtD
Paclitaxel—MAP2—LKB1 signaling events—TP53—cervical cancer	0.000267	0.00876	CbGpPWpGaD
Paclitaxel—ABCC1—female gonad—cervical cancer	0.000267	0.00393	CbGeAlD
Paclitaxel—ABCC1—vagina—cervical cancer	0.000265	0.00391	CbGeAlD
Paclitaxel—MAPT—Apoptotic execution phase—CASP8—cervical cancer	0.000265	0.00869	CbGpPWpGaD
Paclitaxel—Decreased appetite—Topotecan—cervical cancer	0.000264	0.0047	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Topotecan—cervical cancer	0.000262	0.00467	CcSEcCtD
Paclitaxel—Fatigue—Topotecan—cervical cancer	0.000262	0.00466	CcSEcCtD
Paclitaxel—Pain—Topotecan—cervical cancer	0.00026	0.00462	CcSEcCtD
Paclitaxel—Constipation—Topotecan—cervical cancer	0.00026	0.00462	CcSEcCtD
Paclitaxel—MAPT—Apoptotic cleavage of cellular proteins—CASP3—cervical cancer	0.000258	0.00845	CbGpPWpGaD
Paclitaxel—MAPT—Notch Signaling Pathway—NOTCH1—cervical cancer	0.000256	0.0084	CbGpPWpGaD
Paclitaxel—MAPT—LKB1 signaling events—MTOR—cervical cancer	0.000254	0.00833	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00025	0.00822	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Topotecan—cervical cancer	0.00025	0.00445	CcSEcCtD
Paclitaxel—CYP2C8—female reproductive system—cervical cancer	0.00025	0.00368	CbGeAlD
Paclitaxel—Gastrointestinal pain—Topotecan—cervical cancer	0.000248	0.00442	CcSEcCtD
Paclitaxel—MAPT—Apoptotic cleavage of cellular proteins—CTNNB1—cervical cancer	0.000248	0.00815	CbGpPWpGaD
Paclitaxel—ABCC10—lymph node—cervical cancer	0.000242	0.00357	CbGeAlD
Paclitaxel—Urticaria—Topotecan—cervical cancer	0.000241	0.00429	CcSEcCtD
Paclitaxel—TUBB4B—lymph node—cervical cancer	0.000241	0.00355	CbGeAlD
Paclitaxel—Abdominal pain—Topotecan—cervical cancer	0.00024	0.00427	CcSEcCtD
Paclitaxel—Body temperature increased—Topotecan—cervical cancer	0.00024	0.00427	CcSEcCtD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000236	0.00776	CbGpPWpGaD
Paclitaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP8—cervical cancer	0.000234	0.00769	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000234	0.00768	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—WNT5A—cervical cancer	0.000228	0.00747	CbGpPWpGaD
Paclitaxel—CYP2C8—vagina—cervical cancer	0.000226	0.00333	CbGeAlD
Paclitaxel—Hypersensitivity—Topotecan—cervical cancer	0.000224	0.00398	CcSEcCtD
Paclitaxel—CYP2C9—female reproductive system—cervical cancer	0.000222	0.00327	CbGeAlD
Paclitaxel—ABCG2—female gonad—cervical cancer	0.000221	0.00326	CbGeAlD
Paclitaxel—ABCG2—vagina—cervical cancer	0.000219	0.00324	CbGeAlD
Paclitaxel—Asthenia—Topotecan—cervical cancer	0.000218	0.00388	CcSEcCtD
Paclitaxel—Pruritus—Topotecan—cervical cancer	0.000215	0.00382	CcSEcCtD
Paclitaxel—BCL2—ATF-2 transcription factor network—HES1—cervical cancer	0.000214	0.00703	CbGpPWpGaD
Paclitaxel—CYP3A4—renal system—cervical cancer	0.000211	0.00311	CbGeAlD
Paclitaxel—BCL2—Intrinsic Pathway for Apoptosis—CASP8—cervical cancer	0.000209	0.00687	CbGpPWpGaD
Paclitaxel—Diarrhoea—Topotecan—cervical cancer	0.000208	0.0037	CcSEcCtD
Paclitaxel—MAPT—IL-5 Signaling Pathway—STAT3—cervical cancer	0.000208	0.00682	CbGpPWpGaD
Paclitaxel—CYP3A5—female gonad—cervical cancer	0.000205	0.00302	CbGeAlD
Paclitaxel—CYP19A1—lymph node—cervical cancer	0.000204	0.00301	CbGeAlD
Paclitaxel—CYP3A5—vagina—cervical cancer	0.000204	0.003	CbGeAlD
Paclitaxel—Dizziness—Topotecan—cervical cancer	0.000201	0.00357	CcSEcCtD
Paclitaxel—MAPT—Apoptotic execution phase—CASP3—cervical cancer	0.0002	0.00658	CbGpPWpGaD
Paclitaxel—MAPT—Copper homeostasis—CASP3—cervical cancer	0.0002	0.00658	CbGpPWpGaD
Paclitaxel—MAPT—IL-2 Signaling Pathway—STAT3—cervical cancer	0.0002	0.00656	CbGpPWpGaD
Paclitaxel—ABCC2—lymph node—cervical cancer	0.000195	0.00287	CbGeAlD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—CASP8—cervical cancer	0.000193	0.00634	CbGpPWpGaD
Paclitaxel—MAPT—Apoptotic execution phase—CTNNB1—cervical cancer	0.000193	0.00634	CbGpPWpGaD
Paclitaxel—Vomiting—Topotecan—cervical cancer	0.000193	0.00344	CcSEcCtD
Paclitaxel—Rash—Topotecan—cervical cancer	0.000191	0.00341	CcSEcCtD
Paclitaxel—Dermatitis—Topotecan—cervical cancer	0.000191	0.0034	CcSEcCtD
Paclitaxel—CYP1B1—lymph node—cervical cancer	0.000191	0.00281	CbGeAlD
Paclitaxel—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00019	0.00625	CbGpPWpGaD
Paclitaxel—Headache—Topotecan—cervical cancer	0.00019	0.00339	CcSEcCtD
Paclitaxel—MAPT—Alzheimers Disease—CASP8—cervical cancer	0.000189	0.00622	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Cancer Pathway—CASP8—cervical cancer	0.000186	0.00611	CbGpPWpGaD
Paclitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000183	0.006	CbGpPWpGaD
Paclitaxel—Nausea—Topotecan—cervical cancer	0.00018	0.00321	CcSEcCtD
Paclitaxel—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—cervical cancer	0.000177	0.00582	CbGpPWpGaD
Paclitaxel—BCL2—TP53 Network—TP53—cervical cancer	0.000177	0.0058	CbGpPWpGaD
Paclitaxel—BCL2—IL2 signaling events mediated by PI3K—MTOR—cervical cancer	0.000176	0.00577	CbGpPWpGaD
Paclitaxel—BCL2—Ceramide signaling pathway—CASP8—cervical cancer	0.000174	0.0057	CbGpPWpGaD
Paclitaxel—ABCC1—lymph node—cervical cancer	0.000171	0.00253	CbGeAlD
Paclitaxel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000171	0.00561	CbGpPWpGaD
Paclitaxel—MAPT—LPA receptor mediated events—CASP3—cervical cancer	0.00017	0.00557	CbGpPWpGaD
Paclitaxel—CYP3A4—female reproductive system—cervical cancer	0.000169	0.00249	CbGeAlD
Paclitaxel—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP8—cervical cancer	0.000168	0.00552	CbGpPWpGaD
Paclitaxel—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000168	0.00551	CbGpPWpGaD
Paclitaxel—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000168	0.00551	CbGpPWpGaD
Paclitaxel—TUBB—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000166	0.00546	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000165	0.00542	CbGpPWpGaD
Paclitaxel—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000162	0.00532	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—HES1—cervical cancer	0.000161	0.0053	CbGpPWpGaD
Paclitaxel—ABCB1—epithelium—cervical cancer	0.000161	0.00237	CbGeAlD
Paclitaxel—ABCB1—uterine cervix—cervical cancer	0.00016	0.00235	CbGeAlD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000158	0.0052	CbGpPWpGaD
Paclitaxel—BCL2—Intrinsic Pathway for Apoptosis—CASP3—cervical cancer	0.000158	0.0052	CbGpPWpGaD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.000158	0.0052	CbGpPWpGaD
Paclitaxel—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000157	0.00515	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000154	0.00506	CbGpPWpGaD
Paclitaxel—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000153	0.00504	CbGpPWpGaD
Paclitaxel—ABCB1—decidua—cervical cancer	0.000152	0.00224	CbGeAlD
Paclitaxel—MAPT—Kit receptor signaling pathway—STAT3—cervical cancer	0.000152	0.005	CbGpPWpGaD
Paclitaxel—BCL2—Caspase Cascade in Apoptosis—CASP8—cervical cancer	0.000151	0.00497	CbGpPWpGaD
Paclitaxel—MAPT—LKB1 signaling events—TP53—cervical cancer	0.00015	0.00491	CbGpPWpGaD
Paclitaxel—ABCB1—renal system—cervical cancer	0.000149	0.0022	CbGeAlD
Paclitaxel—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000148	0.00487	CbGpPWpGaD
Paclitaxel—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000148	0.00487	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000148	0.00487	CbGpPWpGaD
Paclitaxel—MAPT—Notch Signaling Pathway—STAT3—cervical cancer	0.000148	0.00486	CbGpPWpGaD
Paclitaxel—TUBB—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000147	0.00483	CbGpPWpGaD
Paclitaxel—BCL2—FAS pathway and Stress induction of HSP regulation—CASP3—cervical cancer	0.000146	0.0048	CbGpPWpGaD
Paclitaxel—ABCB1—endometrium—cervical cancer	0.000144	0.00213	CbGeAlD
Paclitaxel—MAPT—Alzheimers Disease—CASP3—cervical cancer	0.000143	0.00471	CbGpPWpGaD
Paclitaxel—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000143	0.00471	CbGpPWpGaD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000143	0.0047	CbGpPWpGaD
Paclitaxel—CYP19A1—FSH signaling pathway—MTOR—cervical cancer	0.000143	0.00468	CbGpPWpGaD
Paclitaxel—ABCG2—lymph node—cervical cancer	0.000142	0.00209	CbGeAlD
Paclitaxel—BCL2—Activation of BH3-only proteins—TP53—cervical cancer	0.000142	0.00466	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Cancer Pathway—CASP3—cervical cancer	0.000141	0.00462	CbGpPWpGaD
Paclitaxel—ABCB1—mammalian vulva—cervical cancer	0.00014	0.00206	CbGeAlD
Paclitaxel—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000139	0.00456	CbGpPWpGaD
Paclitaxel—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000138	0.00452	CbGpPWpGaD
Paclitaxel—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000136	0.00446	CbGpPWpGaD
Paclitaxel—ABCB1—uterus—cervical cancer	0.000133	0.00196	CbGeAlD
Paclitaxel—MAPT—LPA receptor mediated events—EGFR—cervical cancer	0.00013	0.00425	CbGpPWpGaD
Paclitaxel—MAPT—Copper homeostasis—TP53—cervical cancer	0.000128	0.00422	CbGpPWpGaD
Paclitaxel—BCL2—IL-5 Signaling Pathway—STAT3—cervical cancer	0.000128	0.00419	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000126	0.00415	CbGpPWpGaD
Paclitaxel—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CASP8—cervical cancer	0.000126	0.00414	CbGpPWpGaD
Paclitaxel—BCL2—IL-2 Signaling Pathway—STAT3—cervical cancer	0.000123	0.00403	CbGpPWpGaD
Paclitaxel—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000122	0.004	CbGpPWpGaD
Paclitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—cervical cancer	0.000122	0.00399	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—RARB—cervical cancer	0.000122	0.00399	CbGpPWpGaD
Paclitaxel—ABCB1—female reproductive system—cervical cancer	0.00012	0.00176	CbGeAlD
Paclitaxel—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—cervical cancer	0.00012	0.00392	CbGpPWpGaD
Paclitaxel—BCL2—Interleukin-11 Signaling Pathway—STAT3—cervical cancer	0.000118	0.00388	CbGpPWpGaD
Paclitaxel—BCL2—Caspase Cascade in Apoptosis—CASP3—cervical cancer	0.000114	0.00376	CbGpPWpGaD
Paclitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000113	0.0037	CbGpPWpGaD
Paclitaxel—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—cervical cancer	0.000112	0.00366	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—CASP8—cervical cancer	0.000111	0.00364	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—CASP8—cervical cancer	0.000111	0.00363	CbGpPWpGaD
Paclitaxel—ABCB1—female gonad—cervical cancer	0.000109	0.00161	CbGeAlD
Paclitaxel—BCL2—IL-3 Signaling Pathway—STAT3—cervical cancer	0.000109	0.00356	CbGpPWpGaD
Paclitaxel—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000108	0.00356	CbGpPWpGaD
Paclitaxel—ABCB1—vagina—cervical cancer	0.000108	0.0016	CbGeAlD
Paclitaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—STAT3—cervical cancer	0.000105	0.00345	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—CASP8—cervical cancer	0.000104	0.00342	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—CASP8—cervical cancer	0.000104	0.0034	CbGpPWpGaD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.000102	0.00333	CbGpPWpGaD
Paclitaxel—BCL2—Intrinsic Pathway for Apoptosis—TP53—cervical cancer	0.000102	0.00333	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—STAT3—cervical cancer	0.0001	0.0033	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—MTOR—cervical cancer	9.64e-05	0.00317	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	9.46e-05	0.00311	CbGpPWpGaD
Paclitaxel—BCL2—Kit receptor signaling pathway—STAT3—cervical cancer	9.36e-05	0.00307	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	9.35e-05	0.00307	CbGpPWpGaD
Paclitaxel—MAPT—Alzheimers Disease—TP53—cervical cancer	9.19e-05	0.00302	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—CD4—cervical cancer	9.11e-05	0.00299	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Cancer Pathway—TP53—cervical cancer	9.03e-05	0.00296	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—CASP3—cervical cancer	8.87e-05	0.00291	CbGpPWpGaD
Paclitaxel—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	8.65e-05	0.00284	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—CTNNB1—cervical cancer	8.55e-05	0.00281	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—CASP3—cervical cancer	8.4e-05	0.00276	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—CASP3—cervical cancer	8.36e-05	0.00275	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—CTNNB1—cervical cancer	8.06e-05	0.00265	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—NOTCH2—cervical cancer	8.05e-05	0.00264	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—CASP3—cervical cancer	7.87e-05	0.00259	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—CASP3—cervical cancer	7.84e-05	0.00257	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—CASP3—cervical cancer	7.81e-05	0.00256	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—MTOR—cervical cancer	7.64e-05	0.00251	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—CTNNB1—cervical cancer	7.52e-05	0.00247	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—STAT3—cervical cancer	7.45e-05	0.00245	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	7.08e-05	0.00232	CbGpPWpGaD
Paclitaxel—ABCB1—lymph node—cervical cancer	7e-05	0.00103	CbGeAlD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CASP8—cervical cancer	6.94e-05	0.00228	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	6.82e-05	0.00224	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	6.82e-05	0.00224	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—CASP8—cervical cancer	6.8e-05	0.00223	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—CTNNB1—cervical cancer	6.57e-05	0.00216	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	6.3e-05	0.00207	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	6.3e-05	0.00207	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	6.27e-05	0.00206	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—EGFR—cervical cancer	5.99e-05	0.00197	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—RARB—cervical cancer	5.85e-05	0.00192	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	5.75e-05	0.00189	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—MTOR—cervical cancer	5.71e-05	0.00187	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.4e-05	0.00177	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—cervical cancer	5.38e-05	0.00177	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TP53—cervical cancer	5.36e-05	0.00176	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	5.32e-05	0.00175	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CASP3—cervical cancer	5.25e-05	0.00172	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—CASP3—cervical cancer	5.14e-05	0.00169	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	5.12e-05	0.00168	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	5.06e-05	0.00166	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—cervical cancer	5.05e-05	0.00166	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—cervical cancer	5.03e-05	0.00165	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—NOTCH1—cervical cancer	4.98e-05	0.00164	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—CTNNB1—cervical cancer	4.96e-05	0.00163	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	4.59e-05	0.00151	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—UBE3A—cervical cancer	4.54e-05	0.00149	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.54e-05	0.00149	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—cervical cancer	4.5e-05	0.00148	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	4.37e-05	0.00144	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—cervical cancer	4.37e-05	0.00143	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.35e-05	0.00143	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—EGFR—cervical cancer	4.26e-05	0.0014	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—CTNNB1—cervical cancer	4.21e-05	0.00138	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4.19e-05	0.00138	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TERT—cervical cancer	4.11e-05	0.00135	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—cervical cancer	4.01e-05	0.00132	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—NOTCH2—cervical cancer	3.88e-05	0.00127	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	3.6e-05	0.00118	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—cervical cancer	3.58e-05	0.00117	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CASP8—cervical cancer	3.48e-05	0.00114	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TERT—cervical cancer	3.41e-05	0.00112	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—cervical cancer	3.37e-05	0.00111	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—EGFR—cervical cancer	3.34e-05	0.0011	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.32e-05	0.00109	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	3.31e-05	0.00109	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—cervical cancer	3.3e-05	0.00108	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	3.19e-05	0.00105	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TERT—cervical cancer	3.11e-05	0.00102	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CA9—cervical cancer	2.99e-05	0.000981	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CA9—cervical cancer	2.81e-05	0.000923	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.79e-05	0.000916	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—FGFR3—cervical cancer	2.78e-05	0.000912	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DPB1—cervical cancer	2.71e-05	0.000891	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—WNT2—cervical cancer	2.67e-05	0.000877	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CASP3—cervical cancer	2.63e-05	0.000864	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	2.53e-05	0.000829	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—NOTCH1—cervical cancer	2.4e-05	0.000788	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CASP8—cervical cancer	2.37e-05	0.00078	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CA9—cervical cancer	2.12e-05	0.000697	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—cervical cancer	2.12e-05	0.000696	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HLA-DQB1—cervical cancer	2.12e-05	0.000695	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CA9—cervical cancer	2.11e-05	0.000693	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CA9—cervical cancer	2.04e-05	0.000671	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—WNT5A—cervical cancer	2.02e-05	0.000665	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—CTNNB1—cervical cancer	1.98e-05	0.00065	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—CTNNB1—cervical cancer	1.98e-05	0.00065	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD8A—cervical cancer	1.98e-05	0.000649	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MTOR—cervical cancer	1.95e-05	0.000641	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CD4—cervical cancer	1.95e-05	0.00064	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CTNNB1—cervical cancer	1.91e-05	0.000627	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CA9—cervical cancer	1.86e-05	0.00061	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—CTNNB1—cervical cancer	1.85e-05	0.000608	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CA9—cervical cancer	1.84e-05	0.000605	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—CTNNB1—cervical cancer	1.81e-05	0.000594	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CTNNB1—cervical cancer	1.73e-05	0.000569	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.72e-05	0.000563	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CTNNB1—cervical cancer	1.62e-05	0.000533	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—FGFR3—cervical cancer	1.62e-05	0.000531	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—cervical cancer	1.56e-05	0.000514	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CTNNB1—cervical cancer	1.49e-05	0.000488	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CASP8—cervical cancer	1.38e-05	0.000454	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—cervical cancer	1.37e-05	0.00045	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CA9—cervical cancer	1.33e-05	0.000437	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.3e-05	0.000426	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—cervical cancer	1.3e-05	0.000426	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.25e-05	0.000411	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—MTHFR—cervical cancer	1.21e-05	0.000398	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—cervical cancer	1.19e-05	0.000389	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HES1—cervical cancer	1.16e-05	0.000382	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CA9—cervical cancer	1.15e-05	0.000379	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—MTHFR—cervical cancer	1.14e-05	0.000375	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MTOR—cervical cancer	1.14e-05	0.000374	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD4—cervical cancer	1.14e-05	0.000373	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTHFR—cervical cancer	1.02e-05	0.000336	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TERT—cervical cancer	1.02e-05	0.000335	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTNNB1—cervical cancer	1.01e-05	0.000331	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CA9—cervical cancer	1e-05	0.00033	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.92e-06	0.000326	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CA9—cervical cancer	9.39e-06	0.000308	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGFR3—cervical cancer	9.37e-06	0.000307	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOTCH1—cervical cancer	8.79e-06	0.000289	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—STAT3—cervical cancer	8.79e-06	0.000289	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—MTHFR—cervical cancer	8.61e-06	0.000283	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—MTHFR—cervical cancer	8.57e-06	0.000281	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.33e-06	0.000273	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MTHFR—cervical cancer	8.29e-06	0.000272	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—cervical cancer	7.99e-06	0.000262	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—cervical cancer	7.54e-06	0.000248	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—cervical cancer	7.48e-06	0.000245	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTOR—cervical cancer	6.59e-06	0.000216	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—cervical cancer	6.58e-06	0.000216	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA9—cervical cancer	6.19e-06	0.000203	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—cervical cancer	5.84e-06	0.000192	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—cervical cancer	5.4e-06	0.000177	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—cervical cancer	5.09e-06	0.000167	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—cervical cancer	4.68e-06	0.000154	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—cervical cancer	4.63e-06	0.000152	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—cervical cancer	4.08e-06	0.000134	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—cervical cancer	3.81e-06	0.000125	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—cervical cancer	2.51e-06	8.25e-05	CbGpPWpGaD
